This report describes the first case of vancomycin-resistant Enterococcus pneumonia complicated with empyema and lung abscess in an HIV patient and reviews previously published cases of Enterococcus pleuro-pulmonary infection. Our case highlights the rarity of this entity and reviews the risk factors for Enterococcus pleuro-pulmonary infections.
Get full access to this article
View all access options for this article.
References
1.
MoelleringRCJr.Emergence of Enterococcus as a significant pathogen. Clin Infect Dis1992;14:1173–6
2.
BergmanR, TjanDH, SchoutenMA, HaasLE, van ZantenAR.Pleural Enterococcus faecalis empyema: an unusual case. Infection2009;37:56–9. Epub 2007 Oct 31
3.
EscuderoSV, AdradosBG, CamaraGT, RomeralesRA.Enterococcal empyema. An Med Interna1995;12:466
4.
MolinosL, GullonJA, RiesgoC, DominguezMJ, MartinezJ.Community acquired pneumonia due to Enterococcus. An entity for consideration?Enferm Infecc Microbiol Clin1995;13:319
5.
MorrisJF, OkiesJE.Enterococcal lung abscess: medical and surgical therapy. Chest1974;65:688–91
6.
PattersonJE, SweeneyAH, SimmsM, An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore)1995;74:191–200
7.
PorteroJL, PorcelJM, RuizA, Rubio-CaballeroM.Community-acquired pneumonia caused by Enterococcus faecium. Med Clin (Barc)1994;102:316–7
8.
HidronAI, EdwardsJR, PatelJ, NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol2008;29:996–1011
9.
WisplinghoffH, BischoffT, TallentSM, SeifertH, WenzelRP, EdmondMB.Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis2004;39:309–17
SuntharamN, LankfordMG, TrickWE, PetersonLR, NoskinGA.Risk factors for acquisition of vancomycin-resistant enterococci among hematology–oncology patients. Diagn Microbiol Infect Dis2002;43:183–8
12.
FridkinSK, EdwardsJR, CourvalJM, The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med2001;135:175–83
13.
MavromanolakisE, MarakiS, SamonisG, TselentisY, CranidisA.Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother1997;9:203–7
14.
KofteridisDP, MarakiS, MixakiI, MantadakisE, SamonisG.Impact of prolonged treatment with trimethoprim-sulfamethoxazole on the human gut flora. Scand J Infect Dis2004;36:771–2
15.
ElsnerHA, KrugerW, LaufsR, MackD.Septicemia due to susceptible Enterococcus faecalis despite prophylaxis with trimethoprim–sulfamethoxazole. Eur J Clin Microbiol Infect Dis1997;16:620–2
